Dexmedetomidine attenuates lipopolysaccharide-induced inflammation through macrophageal IL-10 expression following α7 nAchR activation.
Int Immunopharmacol
; 109: 108920, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35691275
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lipopolysaccharides
/
Dexmedetomidine
Limits:
Animals
Language:
En
Journal:
Int Immunopharmacol
Journal subject:
ALERGIA E IMUNOLOGIA
/
FARMACOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Netherlands